Analgesic and disease modifying effects of interferential current in psoriatic arthritis

Rheumatology International

Volumn 26, Issue 10, 2006, Pages 904-907

  Walker, U A ^a   Uhl, M ^b   Weiner, S M ^c   Warnatz, K ^a   Lange Nolde, A ^b   Dertinger, H ^d   Peter, H H ^a   Jurenz, S A ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

Electric stimulation therapy; Pain; Psoriasis; Psoriatic arthritis; Therapeutics

Indexed keywords

C REACTIVE PROTEIN; CYCLIC AMP;

ADULT; AGED; ARTICLE; BONE SCINTISCANNING; CLINICAL ARTICLE; DETERIORATION; DISEASE ACTIVITY; DISEASE EXACERBATION; ELECTROSTIMULATION; EROSION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOOT; HAND; HUMAN; INTERFERENTIAL CURRENT; JOINT CAVITY; JOINT STIFFNESS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PRIORITY JOURNAL; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; SHORT FORM 36; SKIN MANIFESTATION; SOFT TISSUE; TENDINITIS; TREATMENT INDICATION; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ADULT; AGED; ANALGESICS; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PAIN MEASUREMENT; PILOT PROJECTS; TIME FACTORS; TRANSCUTANEOUS ELECTRIC NERVE STIMULATION; TREATMENT OUTCOME;

EID: 33745500640     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-006-0102-y     Document Type: Article

References (14)

1. Mease PJ, Goffe BS, Metz J, VanderStoep A, Finck B, Burge DJ (2000) Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet 356:385-390
2. Philipp A, Wolf GK, Rzany B, Dertinger H, Jung EG (2000) Interferential current is effective in palmar psoriaris: an open prospective trial. Eur J Dermatol 10:195-198
3. Sontag W (2000) Modulation of cytokine production by interferential current in differentiated HL-60 cells. Bioelectromagnetics 21:238-244
4. Sontag W (2004) Response of cyclic AMP by DMSO differentiated HL-60 cells exposed to electric interferential current after prestimulation. Bioelectromagnetics 25:176-184
5. Royer E, Chaintreul J, Meynadier J, Michel B, Guilhou JJ, Crastes DP (1982) Cyclic AMP and cyclic GMP production in normal and psoriatic epidermis. Dermatologica 165:533-543
6. Asadullah K, Sabat R, Friedrich M, Volk HD, Sterry W (2004) Interleukin-10: an important immunoregulatory cytokine with major impact on psoriasis. Curr Drug Targets Inflamm Allergy 3:185-192
7. Platzer C, Meisel C, Vogt K, Platzer M, Volk HD (1995) Up-regulation of monocytic IL-10 by tumor necrosis factor-alpha and cAMP elevating drugs. Int Immunol 7:517-523
8. Sontag W, Dertinger H (1998) Response of cytosolic calcium, cyclic AMP, and cyclic GMP in dimethylsulfoxide-differentiated HL-60 cells to modulated low frequency electric currents. Bioelectromagnetics 19:452-458
9. Moll JM, Wright V (1973) Psoriatic arthritis. Semin Arthritis Rheum 3:55-78
10. Wassenberg S, Fischer-Kahle V, Herborn G, Rau R (2001) A method to score radiographic change in psoriatic arthritis. Z Rheumatol 60:156-166
11. Clegg DO, Reda DJ, Mejias E, Cannon GW, Weisman MH, Taylor T, Budiman-Mak E, Blackburn WD, Vasey FB, Mahowald ML, Cush JJ, Schumacher HR Jr, Silverman SL, Alepa FP, Luggen ME, Cohen MR, Makkena R, Haakenson CM, Ward RH, Manaster BJ, Anderson RJ, Ward JR, Henderson WG (1996) Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study. Arthritis Rheum 39:2013-2020
12. Cheing GL, Hui-Chan CW (2003) Analgesic effects of transcutaneous electrical nerve stimulation and interferential currents on heat pain in healthy subjects. J Rehabil Med 35:15-19
13. Johnson MI, Tabasam G (2003) An investigation into the analgesic effects of different frequencies of the amplitude-modulated wave of interferential current therapy on cold-induced pain in normal subjects. Arch Phys Med Rehabil 84:1387-1394
14. McInnes IB, Illei GG, Danning CL, Yarboro CH, Crane M, Kuroiwa T, Schlimgen R, Lee E, Foster B, Flemming D, Prussin C, Fleisher TA, Boumpas DT (2001) 1L-10 improves skin disease and modulates endothelial activation and leukocyte effector function in patients with psoriatic arthritis. J Immunol 167:4075-4082